Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Price:
3.54
USD
3.51%
Market Closed
Market Cap:
$1.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
FREYR Battery Inc
NYSE:TE
|
US |
|
H
|
Hangzhou Electronic Soul Network Technology Co Ltd
SSE:603258
|
CN |
Cash Flow Statement
Cash Flow Statement
Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals Inc
Currency: USD
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(84)
|
(186)
|
(212)
|
(234)
|
(247)
|
(239)
|
(249)
|
(260)
|
(293)
|
(328)
|
(354)
|
(375)
|
(378)
|
(464)
|
(575)
|
(649)
|
(716)
|
(645)
|
|
| Depreciation & Amortization |
4
|
8
|
10
|
10
|
11
|
12
|
13
|
15
|
20
|
24
|
28
|
31
|
31
|
36
|
48
|
63
|
77
|
84
|
|
| Stock-Based Compensation |
10
|
15
|
19
|
19
|
25
|
28
|
31
|
37
|
45
|
54
|
61
|
66
|
67
|
82
|
102
|
111
|
118
|
111
|
|
| Other Non-Cash Items |
12
|
20
|
26
|
29
|
35
|
39
|
44
|
47
|
54
|
66
|
72
|
74
|
84
|
106
|
145
|
165
|
188
|
176
|
|
| Cash Interest Paid |
(0)
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
5
|
(0)
|
126
|
117
|
102
|
105
|
(42)
|
(43)
|
(40)
|
(50)
|
(62)
|
(62)
|
(55)
|
(38)
|
(7)
|
38
|
9
|
14
|
|
| Cash from Operating Activities |
(63)
N/A
|
(159)
-152%
|
(50)
+68%
|
(78)
-55%
|
(100)
-27%
|
(84)
+16%
|
(234)
-180%
|
(240)
-2%
|
(258)
-8%
|
(288)
-11%
|
(317)
-10%
|
(332)
-5%
|
(318)
+4%
|
(359)
-13%
|
(389)
-8%
|
(383)
+1%
|
(441)
-15%
|
(372)
+16%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(34)
|
(40)
|
(25)
|
(35)
|
(34)
|
(37)
|
(38)
|
(25)
|
(18)
|
(12)
|
(13)
|
(11)
|
(14)
|
(14)
|
(9)
|
(11)
|
(7)
|
(6)
|
|
| Other Items |
(184)
|
(232)
|
(84)
|
(63)
|
183
|
230
|
82
|
63
|
2
|
2
|
2
|
(3)
|
(3)
|
274
|
268
|
269
|
266
|
(10)
|
|
| Cash from Investing Activities |
(219)
N/A
|
(272)
-24%
|
(109)
+60%
|
(98)
+10%
|
149
N/A
|
193
+30%
|
45
-77%
|
38
-16%
|
(16)
N/A
|
(10)
+35%
|
(12)
-13%
|
(14)
-18%
|
(18)
-31%
|
260
N/A
|
259
0%
|
258
-1%
|
260
+1%
|
(17)
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
463
|
471
|
471
|
10
|
16
|
154
|
154
|
155
|
157
|
141
|
153
|
412
|
427
|
309
|
337
|
177
|
412
|
533
|
|
| Net Issuance of Debt |
(19)
|
(13)
|
(13)
|
(13)
|
(0)
|
(0)
|
(0)
|
(0)
|
50
|
(1)
|
(1)
|
(1)
|
(53)
|
(4)
|
(6)
|
(9)
|
(8)
|
(8)
|
|
| Other |
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(3)
|
|
| Cash from Financing Activities |
448
N/A
|
459
+2%
|
458
0%
|
(3)
N/A
|
11
N/A
|
154
+1 317%
|
154
0%
|
155
+1%
|
207
+33%
|
140
-32%
|
152
+9%
|
411
+170%
|
374
-9%
|
304
-19%
|
331
+9%
|
165
-50%
|
400
+142%
|
522
+30%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(3)
|
2
|
11
|
12
|
18
|
|
| Net Change in Cash |
167
N/A
|
28
-83%
|
299
+961%
|
(179)
N/A
|
60
N/A
|
264
+340%
|
(36)
N/A
|
(47)
-32%
|
(68)
-43%
|
(158)
-133%
|
(176)
-12%
|
66
N/A
|
39
-41%
|
202
+422%
|
203
+1%
|
51
-75%
|
231
+353%
|
151
-35%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(97)
N/A
|
(198)
-105%
|
(75)
+62%
|
(113)
-51%
|
(133)
-18%
|
(121)
+10%
|
(272)
-126%
|
(265)
+2%
|
(276)
-4%
|
(300)
-8%
|
(330)
-10%
|
(342)
-4%
|
(332)
+3%
|
(373)
-12%
|
(398)
-7%
|
(394)
+1%
|
(448)
-14%
|
(378)
+16%
|
|
Switch to:
Switch to:
See Also
Discover More
